GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Return-on-Tangible-Asset

Center Laboratories (ROCO:4123) Return-on-Tangible-Asset : -8.25% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Center Laboratories's annualized Net Income for the quarter that ended in Mar. 2024 was NT$-2,164 Mil. Center Laboratories's average total tangible assets for the quarter that ended in Mar. 2024 was NT$26,227 Mil. Therefore, Center Laboratories's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -8.25%.

The historical rank and industry rank for Center Laboratories's Return-on-Tangible-Asset or its related term are showing as below:

ROCO:4123' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -9.55   Med: 1.78   Max: 23.27
Current: -9.55

During the past 13 years, Center Laboratories's highest Return-on-Tangible-Asset was 23.27%. The lowest was -9.55%. And the median was 1.78%.

ROCO:4123's Return-on-Tangible-Asset is ranked worse than
68.79% of 1083 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs ROCO:4123: -9.55

Center Laboratories Return-on-Tangible-Asset Historical Data

The historical data trend for Center Laboratories's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Return-on-Tangible-Asset Chart

Center Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.33 14.93 6.23 0.37 -3.88

Center Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.23 -13.89 -14.75 -1.15 -8.25

Competitive Comparison of Center Laboratories's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Return-on-Tangible-Asset falls into.



Center Laboratories Return-on-Tangible-Asset Calculation

Center Laboratories's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-995.421/( (25184.36+26176.317)/ 2 )
=-995.421/25680.3385
=-3.88 %

Center Laboratories's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-2163.908/( (26176.317+26276.868)/ 2 )
=-2163.908/26226.5925
=-8.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Center Laboratories  (ROCO:4123) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Center Laboratories Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories (ROCO:4123) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company provides solutions to special medication needs of infants, young children, the elderly, patients with dysphagia and special population. In addition to the diversification of new formulations of oral solution, Center Laboratories is dedicated to new drug development of CNS and pain treatment.

Center Laboratories (ROCO:4123) Headlines

No Headlines